Clinical Trials Browser

Phase 4 × Lymphoma, T-Cell, Peripheral × Lenalidomide × Clear all

NCT04040491 2020-05-12

PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma

Phase 4 Unknown

Lymphoma, T-Cell, Peripheral